Suppr超能文献

小鼠冠状动脉血管腺苷受体的功能特性

Functional characterization of coronary vascular adenosine receptors in the mouse.

作者信息

Flood A, Headrick J P

机构信息

National Heart Foundation Research Centre, School of Health Science, Griffith University, Southport, QLD 4217, Australia.

出版信息

Br J Pharmacol. 2001 Aug;133(7):1063-72. doi: 10.1038/sj.bjp.0704170.

Abstract

Coronary responses to adenosine agonists were assessed in perfused mouse and rat hearts. The roles of nitric oxide (NO) and ATP-dependent K(+) channels (K(ATP)) were studied in the mouse. Resting coronary resistance was lower in mouse vs rat, as was minimal resistance (2.2+/-0.1 vs 3.8+/-0.2 mmHg ml(-1) min(-1) g(-1)). Peak hyperaemic flow after 20 - 60 s occlusion was greater in mouse. Adenosine agonists induced coronary dilation in mouse, with pEC(50)s of 9.4+/-0.1 for 2-[p-(2-carboxyethyl)phenethylamino]-5'-N-ethyl carboxamidoadenosine (CGS21680, A(2A)-selective agonist), 9.3+/-0.1 for 5'-N-ethylcarboxamidoadenosine (NECA, A(1)/A(2) agonist), 8.4+/-0.1 for 2-chloroadenosine (A(1)/A(2) agonist), 7.7+/-0.1 for N(6)-(R)-(phenylisopropyl)adenosine (R-PIA, A(1)/A(2B) selective), and 6.8+/-0.2 for adenosine. The potency order (CGS21680=NECA>2-chloroadenosine>R-PIA>adenosine) supports A(2A) adenosine receptor-mediated dilation in mouse coronary vessels. 0.2 - 2 microM of the A(2B)-selective antagonist alloxazine failed to alter CGS21680 or 2-chloroadenosine responses. pEC(50)s in rat were 6.7+/-0.2 for CGS21680, 7.3+/-0.1 for NECA, 7.6+/-0.1 for 2-chloroadenosine, 7.2+/-0.1 for R-PIA, and 6.2+/-0.1 for adenosine (2-chloroadenosine>NECA=R-PIA>CGS21680> adenosine), supporting an A(2B) adenosine receptor response. NO-synthase antagonism with 50 microM N(G)-nitro L-arginine (L-NOARG) increased resistance by approximately 25%, and inhibited responses to CGS21680 (pEC(50)=9.0+/-0.1), 2-chloroadenosine (pEC(50)=7.3+/-0.2) and endothelial-dependent ADP, but not sodium nitroprusside (SNP). K(ATP) channel blockade with 5 microM glibenclamide increased resistance by approximately 80% and inhibited responses to CGS21680 in control (pEC(50)=8.3+/-0.1) and L-NOARG-treated hearts (pEC(50)=7.3+/-0.1), and to 2-chloroadenosine in control (pEC(50)=6.7+/-0.1) and L-NOARG-treated hearts (pEC(50)=5.9+/-0.2). In summary, mouse coronary vessels are more sensitive to adenosine than rat vessels. A(2A) adenosine receptors mediate dilation in mouse coronary vessels vs A(2B) receptors in rat. Responses in the mouse involve a sensitive NO-dependent response and K(ATP)-dependent dilation.

摘要

在灌注的小鼠和大鼠心脏中评估了冠状动脉对腺苷激动剂的反应。在小鼠中研究了一氧化氮(NO)和ATP依赖性钾通道(KATP)的作用。小鼠的静息冠状动脉阻力低于大鼠,最小阻力也是如此(2.2±0.1对3.8±0.2 mmHg ml-1 min-1 g-1)。20 - 60秒闭塞后的峰值充血流量在小鼠中更大。腺苷激动剂在小鼠中诱导冠状动脉扩张,2-[对-(2-羧乙基)苯乙氨基]-5'-N-乙基羧酰胺腺苷(CGS21680,A2A选择性激动剂)的pEC50为9.4±0.1,5'-N-乙基羧酰胺腺苷(NECA,A1/A2激动剂)为9.3±0.1,2-氯腺苷(A1/A2激动剂)为8.4±0.1,N6-(R)-(苯异丙基)腺苷(R-PIA,A1/A2B选择性)为7.7±0.1,腺苷为6.8±0.2。效价顺序(CGS21680 = NECA>2-氯腺苷>R-PIA>腺苷)支持A2A腺苷受体介导的小鼠冠状动脉扩张。0.2 - 2 microM的A2B选择性拮抗剂咯嗪未能改变CGS21680或2-氯腺苷的反应。大鼠中CGS21680的pEC50为6.7±0.2,NECA为7.3±0.1,2-氯腺苷为7.6±0.1,R-PIA为7.2±0.1,腺苷为6.2±0.1(2-氯腺苷>NECA = R-PIA>CGS21680>腺苷),支持A2B腺苷受体反应。用50 microM N(G)-硝基-L-精氨酸(L-NOARG)拮抗NO合酶使阻力增加约25%,并抑制对CGS21680(pEC50 = 9.0±0.1)、2-氯腺苷(pEC50 = 7.3±0.2)和内皮依赖性ADP的反应,但不抑制硝普钠(SNP)的反应。用5 microM格列本脲阻断KATP通道使阻力增加约80%,并抑制对照(pEC50 = 8.3±0.1)和L-NOARG处理的心脏中对CGS21680的反应(pEC50 = 7.3±0.1),以及对照(pEC50 = 6.7±0.1)和L-NOARG处理的心脏中对2-氯腺苷的反应(pEC50 = 5.9±0.2)。总之,小鼠冠状动脉比大鼠血管对腺苷更敏感。A2A腺苷受体介导小鼠冠状动脉扩张,而大鼠中为A2B受体。小鼠中的反应涉及敏感的NO依赖性反应和KATP依赖性扩张。

相似文献

引用本文的文献

9
Cardiac purinergic signalling in health and disease.健康与疾病中的心脏嘌呤能信号传导
Purinergic Signal. 2015 Mar;11(1):1-46. doi: 10.1007/s11302-014-9436-1. Epub 2014 Dec 20.

本文引用的文献

7
Examination of adenosine receptor-mediated relaxation of the pig coronary artery.猪冠状动脉中腺苷受体介导的舒张作用研究。
Clin Exp Pharmacol Physiol. 1999 May-Jun;26(5-6):438-43. doi: 10.1046/j.1440-1681.1999.03054.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验